Previous 10 | Next 10 |
Solid growth of Mineral Resources -- Inaugural Indicated Mineral Resource declared at EPO (All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG)...
TORONTO, March 23, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) is pleased to report results from the 2022 drilling program at EPO, a deposit located to the north of the Media Luna deposit in close proximity to the Guajes Tun...
Program successful in upgrading Indicated Resources to the Measured category and adding Inferred Resources along the boundaries of the deposit (All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, March 08, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “C...
Summary PacBio's fourth quarter numbers were ugly, but that was expected as the company prepares for the launch of its next generation of long-read sequencers and its entry into short-read sequencing. The Revio long-read sequencer offers another significant step up in throughput and cos...
Delivers on full year production and cost guidance; exits the year with liquidity of $622 million (All amounts expressed in U.S. Dollars unless otherwise stated) TORONTO, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX:...
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference PR Newswire PLEASANTON, Calif. , Feb. 22, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced th...
10x Genomics ( NASDAQ: TXG ) is up 10% in Thursday morning trading after Street firm reacted positively to the company's Q4 2022 results and 2023 guidance. The life science technology company beat on the top and bottom lines . While 10x Genomics ( TXG ) provided 2023 reven...
10x Genomics ( NASDAQ: TXG ) is trading 10% higher after the company posted better-than-expected Q4 result, helped by higher consumables revenue in the Americas and EMEA. Q4 GAAP EPS of -$0.15 beat by $0.17, while revenue of $156.2M (+8.9% Y/Y) beats by $8.03M. Gross marg...
10x Genomics, Inc. (TXG) Q4 2022 Earnings Conference Call February 15, 2023, 04:30 PM ET Company Participants Cassie Corneau - Head, Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin McAnear - Chief Financial Off...
10x Genomics press release ( NASDAQ: TXG ): Q4 GAAP EPS of -$0.15 beats by $0.17 . Revenue of $156.2M (+8.9% Y/Y) beats by $8.03M . 2023 Financial Guidance 10x Genomics expects full year 2023 revenue to be in the range of $580 million to $600 million vs $613.96M co...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:09 ET Kyle Mikson from Canaccord Genuity issued a price target of $32.00 for TXG on 2024-07-23 05:09:00. The adjusted price target was set to $32.00. At the time of the announcement, TXG was trading at $18.11. The overall price target consensus is at $24...
10x Genomics to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLEASANTON, Calif. , July 12, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report fi...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 248.0% to $0.6682 on volume of 430,252,408 shares Maxeon Solar Technologies Ltd. (MAXN) fell 15.0% to $0.2108 on volume of 237,403,092 shares NVIDIA Corporation (NVDA) rose 2.7% to $134.91 on vol...